Japan-based Chiome Bioscience has agreed to terminate the License Agreement for anti-TROP-2 antibody ( LIV-20...
Japan headquartered firm Eisai has launched its pharmaceutical sales subsidiary, a fully-fledged operations and bus...
European biotech firm Alvotech and Japanese pharmaceutical company Fuji Pharma have decided to expand their existing exc...
Asieris Pharmaceuticals, a China-based biopharma company specialising in discovering, developing and commercialising inn...
Since it is practically impossible to evaluate all interactions between new drug candidates and all marketed drugs durin...
Japan-based Toray Industries, Inc., has announced that Korean marketing partner SK Chemicals Co. has begun selling REMIT...
Why does multiple sclerosis (MS) deserve attention and investment in APAC for the development of novel treatments? ...
US-based Selecta Biosciences, and Japanese firm Astellas Pharma have announced an exclusive licensing and development ag...
RespireRx (Formerly Known As Cortex Pharmaceuticals) has established ResolutionRx Ltd, a new, currently wholly-owned, un...
An option and research collaboration agreement has been established between Australia's Monash University and Japan-base...
Canada's FSD Pharma has announced the incorporation of a new subsidiary to capitalise on drug development incentive...
Clarivate Plc, has announced the release of its 10th annual Drugs to Watch™ report sharing in-depth...
Australian medical technology company LBT Innovations, a leader in medical technology automation using artificial ...
PharmaEssentia Corporation, a global biopharmaceutical innovator headquartered in Taiwan leveraging deep expertise and p...
Japanese headquartered Chugai Pharmaceutical has already developed world-class technologies for antibody engineeri...
South Korean firm Alteogen Inc has entered into an exclusive license agreement with Sandoz AG. Under the terms of t...
PeptiDream Inc., , Japan-based biopharmaceutical company, has announced new multi-target collaboration and license agree...
UK-headquartered Hikma Pharmaceuticals has announced a new exclusive licensing and commercialisation agree...
Indian pharmaceutical company Hetero has announced the receipt of World Health Organisation Prequalification of Medicine...
Denmark-based LEO Pharma A/S, a global leader in medical dermatology, has announced that the Japan Ministry of Health, L...
Hyphens Pharma International, Singapore's specialty pharmaceutical and consumer healthcare group, has announced tha...
South Korea-based LegoChem Biosciences, Inc. (LCB) has entered into a research collaboration and license agree...
Astellas Pharma Inc., Eisai Co., Daiichi Sankyo Company and Takeda Pharmaceutical have agreed on collaboration to reduce...
Merck, and Kelun-Biotech (a holding subsidiary of Sichuan Kelun Pharmaceutical in China), a clinical-stage biotech compa...
Renewing its commitment to innovation in Japan and to Shonan Health Innovation Park (Shonan iPark), Japan-based Takeda P...
